Filing Details
- Accession Number:
- 0001127602-17-010729
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-03-08 08:05:54
- Reporting Period:
- 2017-03-06
- Filing Date:
- 2017-03-08
- Accepted Time:
- 2017-03-08 08:05:54
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 882796 | Biocryst Pharmaceuticals Inc | BCRX | Biological Products, (No Disgnostic Substances) (2836) | 621413174 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1230708 | Ii R Thomas Staab | 4505 Emperor Blvd. Suite 200 Durham NC 27703 | Senior Vice President And Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-03-06 | 3,250 | $3.78 | 120,563 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-03-06 | 3,250 | $7.90 | 117,313 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Emp. Stock Option (Right to Buy) | Disposition | 2017-03-06 | 3,250 | $0.00 | 3,250 | $3.78 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 92,760 | 2012-07-01 | 2021-07-01 | No | 4 | M | Direct |
Footnotes
- This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 26, 2016.
Billionaire Hedge Funds
